2024 | Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial | AGE AND AGEING |
2024 | Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale
| JOURNAL OF STROKE |
2024 | Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock
| SCIENTIFIC REPORTS |
2024 | Optimal antithrombotic strategy in patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation: Design and rationale of the randomized ADAPT AF-DES trial | AMERICAN HEART JOURNAL |
2024 | Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial | DIABETES OBESITY & METABOLISM |
2024 | Comparison of Intracardiac Echocardiography Versus Transesophageal Echocardiography for Guidance During Transcatheter Aortic Valve Replacement
| KOREAN CIRCULATION JOURNAL |
2024 | Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial | CIRCULATION |
2023 | Association Between Body Mass Index and Clinical Outcomes According to Diabetes in Patients Who Underwent Percutaneous Coronary Intervention
| KOREAN CIRCULATION JOURNAL |
2023 | Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial | ATHEROSCLEROSIS |
2023 | Magnetocardiography at rest predicts cardiac death in patients with acute chest pain
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2023 | Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes | JACC-CARDIOVASCULAR INTERVENTIONS |
2023 | Association of Prophylactic Distal Perfusion Cannulation With Mortality in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation | AMERICAN JOURNAL OF CARDIOLOGY |
2023 | ADSC secretome constrains NK cell activity by attenuating IL-2-mediated JAK-STAT and AKT signaling pathway via upregulation of CIS and DUSP4
| STEM CELL RESEARCH & THERAPY |
2023 | Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
| SCIENTIFIC REPORTS |
2023 | Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
| BMJ-BRITISH MEDICAL JOURNAL |
2023 | Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention | AMERICAN JOURNAL OF MEDICINE |
2023 | Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
| ECLINICALMEDICINE |
2023 | Efficacy of Percutaneous Coronary Intervention With Synergy Stents in Patients Aged ≥75 Years: 1-Year Clinical Outcomes from the Synergy Elderly Registry | AMERICAN JOURNAL OF CARDIOLOGY |
2023 | Author's Reply to Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt
| KOREAN CIRCULATION JOURNAL |
2023 | Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial | JAMA CARDIOLOGY |
2023 | Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease
| CIRCULATION JOURNAL |
2023 | Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents
| CARDIOLOGY JOURNAL |
2023 | MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation | EUROPEAN HEART JOURNAL |
2023 | Impact of intravascular ultrasound in acute myocardial infarction patients at high ischemic risk | REVISTA ESPANOLA DE CARDIOLOGIA |
2023 | Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
2023 | Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial | AMERICAN HEART JOURNAL |
2023 | Device Effectiveness for Femoropopliteal Artery Disease Treatment: An Analysis of K-VIS ELLA Registry | JACC-CARDIOVASCULAR INTERVENTIONS |
2023 | Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY |
2023 | Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease | REVISTA ESPANOLA DE CARDIOLOGIA |
2023 | Does Age Matter After Successful Left Atrial Appendage Closure?
| JACC: Asia |
2023 | Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial
| ECLINICALMEDICINE |
2023 | Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
2023 | Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
2023 | Effects of Hypertension on Two-Year Outcomes According to Glycemic Status in Patients With Acute Myocardial Infarction Receiving Newer-Generation Drug-Eluting Stents | ANGIOLOGY |
2023 | Stent expansion evaluated by optical coherence tomography and subsequent outcomes
| SCIENTIFIC REPORTS |
2023 | Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2023 | Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial | EUROPEAN HEART JOURNAL |
2023 | Assessment of fractional flow reserve in intermediate coronary stenosis using optical coherence tomography-based machine learning
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2022 | Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: Results of KAMIR Registry
| CARDIOLOGY JOURNAL |
2022 | Prediabetes versus type 2 diabetes in patients with acute myocardial infarction and current smoking | AMERICAN JOURNAL OF THE MEDICAL SCIENCES |
2022 | Percutaneous Patent Foramen Ovale Closure After Stroke
| KOREAN CIRCULATION JOURNAL |
2022 | Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium | JACC-CARDIOVASCULAR INTERVENTIONS |
2022 | Clinical significance of right ventricular-pulmonary arterial coupling in patients with tricuspid regurgitation before closure of atrial septal defect
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2022 | Optical coherence tomography in coronary atherosclerosis assessment and intervention
| NATURE REVIEWS CARDIOLOGY |
2022 | Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2022 | Percutaneous Treatment of Recurrent Stroke Caused by a Cardiac Foreign Body: A Case Report
| Korean Journal of Medicine |
2022 | Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study
| CARDIOLOGY JOURNAL |
2022 | Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
| BMC MEDICINE |
2022 | Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2022 | Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial | EUROINTERVENTION |